Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 9/20 | 0.81 |
| ▸ | MAPT | P10636 | 4/20 | 0.81 |
| ▸ | MEN1 | O00255 | 4/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.81 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.81 |
| ▸ | HTT | P42858 | 2/20 | 0.81 |
| ▸ | HPGD | P15428 | 2/20 | 0.81 |
| ▸ | RECQL | P46063 | 2/20 | 0.81 |
| ▸ | BLM | P54132 | 2/20 | 0.81 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.81 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.81 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.81 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.81 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluorescein SCHEMBL3038291 | 0.99 | FTO (0.79) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL4807011 | 0.99 | FTO (0.82) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL1290524 | 0.94 | FTO (0.87) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL17867543 | 0.91 | FTO (0.97) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL18630551 | 0.90 | FTO (0.81) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL27087693 | 0.90 | FTO (0.94) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL1198361 | 0.90 | FTO (0.94) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL30272223 | 0.90 | FTO (1.00) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL29371199 | 0.90 | FTO (1.00) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL29388667 | 0.90 | FTO (1.00) | FTOMAPTMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4348347-A2 | SYSTEM AND METHOD FOR HIGH RESOLUTION 3D NANOFABRICATION | Irradiant Technologies Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| CN-117813548-A | System and method for high resolution three-dimensional nanofabrication | 光辉科技股份有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117530285-A | Sterilization composition | 华东理工大学 | 2024-02-09 | — | — | CN | claimed |
| WO-2022251546-A2 | SYSTEM AND METHOD FOR HIGH RESOLUTION 3D NANOFABRICATION | Irradiant Technologies Inc. (US) | 2022-12-01 | — | — | WO | claimed |
| EP-2686022-B1 | IMPROVED GLYCAN ARRAYS AND METHODS FOR THEIR FABRICATION | OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU SEMIOTIK (RU) | 2018-08-22 | — | — | EP | claimed |
| US-9494515-B2 | Glycan arrays and methods for their fabrication | Obschestvo s organichennoy oivetstvennostyu “SEMIOTIK” (RU) | 2016-11-15 | — | — | US | claimed |
| EP-2686022-A1 | IMPROVED GLYCAN ARRAYS AND METHODS FOR THEIR FABRICATION | Obschestvo s Ogranichennoy Otvetstvennostyu "Semiotik" (RU) | 2014-01-22 | — | — | EP | claimed |
| CN-103402548-A | Improved glycan arrays and methods of making the same | OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU SYNTHAUR | 2013-11-20 | — | — | CN | claimed |
| US-20130288928-A1 | GLYCAN ARRAYS AND METHODS FOR THEIR FABRICATION | OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "SEMIOTIK" (RU) | 2013-10-31 | — | — | US | claimed |
| WO-2012091606-A1 | IMPROVED GLYCAN ARRAYS AND METHODS FOR THEIR FABRICATION | OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "SYNTHAUR" (RU) | 2012-07-05 | — | — | WO | claimed |
| EP-0853680-B1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | EMD BIOSCIENCES INC (US) | 2004-03-31 | — | — | EP | claimed |
| EP-0853680-A4 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN INC (US) | 2000-09-13 | — | — | EP | claimed |
| EP-0853680-A1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN, INC. (US) | 1998-07-22 | — | — | EP | claimed |
| WO-1997012994-A1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN, INC. (US) | 1997-04-10 | — | — | WO | claimed |
| WO-2024148174-A1 | PEPTIDE SEQUENCER | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024059954-A1 | THIOL-ENE HYDROGEL | ALLARTA LIFE SCIENCE INC. (CA) | 2024-03-28 | — | — | WO | disclosed |
| US-20240101733-A1 | MONOGLYCEROL ACRYLATE BASED POLYMER AND USES THEREOF | UNIVERSITé LAVAL (CA) | 2024-03-28 | — | — | US | disclosed |
| CN-1214348-A | Divalent reactive water-soluble polymer derivative and complex containing the same | MITSUBISHI CHEM CORP (JP) | 1999-04-21 | — | — | CN | disclosed |
| EP-0903152-A2 | Bifunctional water-soluble polymer derivative and complex containing it | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-03-24 | — | — | EP | disclosed |
| WO-1998015829-A1 | ANALYSIS OF CARBOHYDRATES | AMERSHAM INTERNATIONAL PLC (GB) | 1998-04-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101733-A1 | MONOGLYCEROL ACRYLATE BASED POLYMER AND USES THEREOF | PLA2G2A, PHOSPHO1, PLA2G4A | FTO 4601/4885MAPT 2180/4885MEN1 817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.